7Baggers
 Published on: 2025-11-17 14:13:43  newser.com Mon, 17 Nov 2025 20:13:43 GMT

Lipella Pharmaceuticals Inc.
(NASDAQ:LIPO) 

LIPO stock logo

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic...

Founded: 2005
IPO Price: $5.75 (Dec 20, 2022)
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends